Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 401 entries
View as:

Liver Biopsy Following Gene Therapy For Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT05932914 Org: User:
Start: 05/31/25 End: 05/31/26 Due: 05/31/27

CD123-Directed Autologous T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

Phase: N/A Priority: Normal
NCT ID: NCT04318678 Org: User:
Start: 07/29/20 End: 07/01/26 Due: 07/01/27

Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00145639 Org: User:
Start: 05/31/99 End: 05/31/06 Due: 05/31/07

Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting

Phase: N/A Priority: Normal
NCT ID: NCT01673243 Org: User:
Start: 09/30/12 End: 07/31/14 Due: 07/31/15

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04881240 Org: User:
Start: 02/14/24 End: 06/30/27 Due: 06/30/28

Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00902213 Org: User:
Start: 11/30/09 End: 05/31/15 Due: 05/31/16

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

Phase: N/A Priority: Normal
NCT ID: NCT05164016 Org: User:
Start: 06/29/22 End: 12/31/27 Due: 12/31/28

Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00152139 Org: User:
Start: 05/31/02 End: 01/31/09 Due: 01/31/10

Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT05685199 Org: User:
Start: 05/10/24 End: 03/31/30 Due: 03/31/31

Reduction of Environmental Tobacco Smoke (ETS) Exposure In Pediatric Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00766766 Org: User:
Start: 09/30/02 End: 06/30/10 Due: 06/30/11

Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI

Phase: N/A Priority: Normal
NCT ID: NCT03187977 Org: User:
Start: 08/03/17 End: 10/13/21 Due: 10/13/22

Massive Iron Deposit Assessment

Phase: N/A Priority: Normal
NCT ID: NCT01572922 Org: User:
Start: 06/11/12 End: 02/28/18 Due: 02/28/19

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04065776 Org: User:
Start: 08/28/19 End: 07/31/28 Due: 07/31/29

Writing Intervention With Adolescents and Young Adults With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05975333 Org: User:
Start: 08/02/23 End: 12/31/25 Due: 12/31/26

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT02661373 Org: User:
Start: 03/01/16 End: 03/09/18 Due: 03/09/19

Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00186862 Org: User:
Start: 08/31/98 End: 10/31/07 Due: 10/31/08

Evaluation of Proton Therapy in Pediatric Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03223766 Org: User:
Start: 08/01/17 End: 07/31/37 Due: 07/31/38

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Phase: N/A Priority: Normal
NCT ID: NCT06098430 Org: User:
Start: 04/04/24 End: 01/31/28 Due: 01/31/29

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00539591 Org: User:
Start: 05/09/08 End: 05/31/26 Due: 05/31/27

Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

Phase: N/A Priority: Normal
NCT ID: NCT05849155 Org: User:
Start: 12/12/23 End: 10/31/28 Due: 10/31/29

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02114229 Org: User:
Start: 05/14/14 End: 09/30/27 Due: 09/30/28

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06289673 Org: User:
Start: 12/26/24 End: 05/31/39 Due: 05/31/40

Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere

Phase: N/A Priority: Normal
NCT ID: NCT03825341 Org: User:
Start: 06/10/19 End: 01/20/22 Due: 01/20/23

Stem Cell Transplantation for Children Affected With Osteopetrosis

Phase: N/A Priority: Normal
NCT ID: NCT00145587 Org: User:
Start: 07/31/04 End: 02/28/09 Due: 02/28/10

Exploring Adherence Monitoring in Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT03708731 Org: User:
Start: 03/12/19 End: 09/30/26 Due: 09/30/27